Related Experiment Video
Updated: Aug 10, 2026
07:29
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Plasma lipoproteins in chronic obstructive pulmonary disease
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|December 1, 1987
Summary
This study found plasma lipoprotein profiles in chronic obstructive pulmonary disease (COPD) patients are similar to non-COPD individuals. This suggests reduced coronary atherosclerosis is not the sole reason for lower heart disease rates in COPD.
Area of Science:
- Cardiology
- Pulmonology
- Biochemistry
Background:
- Chronic obstructive pulmonary disease (COPD) is associated with a lower prevalence of angina and myocardial infarction.
- The role of plasma lipoprotein fractions in this phenomenon requires further investigation.
Purpose of the Study:
- To compare plasma lipoprotein profiles between patients with COPD and non-COPD subjects.
- To investigate the relationship between lipoprotein fractions and the risk of atherosclerosis in COPD.
Main Methods:
- Plasma lipoprotein fractions were analyzed in 29 COPD patients and compared to a control group.
- Key lipid parameters including triglycerides were assessed.
Main Results:
- Triglyceride levels were significantly lower in female COPD patients compared to controls.
- Other plasma lipoprotein parameters were largely similar between COPD and non-COPD subjects.
- The atherosclerosis index did not significantly differ between the two groups.
Conclusions:
- Plasma lipoprotein profiles show minimal differences in COPD patients compared to non-COPD individuals.
- Reduced coronary atherosclerosis may not be the sole explanation for the lower incidence of cardiovascular events in COPD.
- Further research is needed to elucidate the protective mechanisms against cardiovascular disease in COPD.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...